The aim of this randomised controlled trial is to investigate the effectiveness of periodic CGM (continuous glucose monitoring) to support a person-centered approach versus self-monitoring of blood glucose (SMBG) in adults with type 2 diabetes on glucose control and patient reported outcomes.
This is a 16-week prospective, multicenter, randomised, open-labelled, two-armed study in adults with type 2 diabetes conducted at primary care practices in Sweden. Periodic CGM group- Intervention group: The participants in the intervention group will be provided with FreeStyle Libre (Abbott Diabetes Care). Participants wear the sensor and check their glucose level for a period of 28 days (14 days X 2) during week 0-4 and week 10-13.Patient's measurement data from the FreeStyle Libre system 2 will be transferred to the OneTwo Analytics (DDA) analysis tool for an automated analysis and this Insight report will be presented to the participants at visit week 4 (digital) and at visit week 16 (clinical). The diabetes nurse and the patient reviews and discuss trends, patterns, and challenges to support the person's self-care management of their type 2 diabetes. This approach is intended to facilitate communication and patient participation and create the conditions for shared informed decisions and health planning. Self-monitoring of blood glucose, SMBG and usual care - Control Group The participants in the control group perform SMBG testing as usual including fasting, pre- or post-prandial measurements. They also receive usual care which comprises consultation with physician diabetes specialist or diabetes nurse depending on individual health care needs.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
400
The patients are also instructed to continue to perform SMBG by finger prick if they experience symptoms of hypo- or hyperglycemia. During visit 0 (baseline) the patients is also instructed about how they can log in to the National Diabetes Register (NDR) to access their own NDR's recorded data and use the diabetes questionnaire.
Sophiahemmet University
Stockholm, Sweden
RECRUITINGHbA1c
mmol/mol
Time frame: change at week 16
Percentage of time spent in range (Glucose)
3.9-10 mmol/l as analyzed by OneTwo Analytics CE marked Decision support Clinic
Time frame: change first 28 days in the study compared with the last 28 days
Percentage time spent in hyperglycaemia
\> 10 mmol/L as analyzed by OneTwo Analytics CE marked Decision support Clinic
Time frame: change first 28 days in the study compared with the last 28 days
Percentage time spent in hypoglycaemia
\< 3.9 mmol/L as analyzed by OneTwo Analytics CE marked Decision support Clinic
Time frame: change first 28 days in the study compared with the last 28 days
Average glucose value
mmol/L as analyzed by OneTwo Analytics CE marked Decision support Clinic
Time frame: change first 28 days in the study compared with the last 28 days
Standard deviation for glucose value
SD as analyzed by OneTwo Analytics CE marked Decision support Clinic
Time frame: change first 28 days in the study compared with the last 28 days
Percentage time in euglycemia, time in target
3.9-8.0 mmol/L as analyzed by OneTwo Analytics CE marked Decision support Clinic
Time frame: change first 28 days in the study compared with the last 28 days
Number of hyperglycemic episodes per day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Number of hyperglycemic episodes per day as analyzed by OneTwo Analytics CE marked Decision support Clinic
Time frame: change first 28 days in the study compared with the last 28 days
Number of hypoglycemic episodes per day
Number of hypoglycemic episodes per day as analyzed by OneTwo Analytics CE marked Decision support Clinic
Time frame: change first 28 days in the study compared with the last 28 days
Data availability in % of all time
Data availability in % of all time as analyzed by OneTwo Analytics CE marked Decision support Clinic
Time frame: change first 28 days in the study compared with the last 28 days
Prandial delta within 2 hours, post - pre-prandial values for breakfast, lunch and dinner.
Prandial delta within 2 hours, post - pre-prandial values for breakfast, lunch and dinner as analyzed by OneTwo Analytics CE marked Decision support Clinic
Time frame: change first 28 days in the study compared with the last 28 days
Postprandial peak during 2 hours for breakfast, lunch and dinner.
Postprandial peak during 2 hours for breakfast, lunch and dinner as analyzed by OneTwo Analytics CE marked Decision support Clinic
Time frame: change first 28 days in the study compared with the last 28 days
Night-time insulin effect
Night-time insulin effect as analyzed by OneTwo Analytics CE marked Decision support Clinic
Time frame: change first 28 days in the study compared with the last 28 days
Fasting glucose level
Fasting glucose level as analyzed by OneTwo Analytics CE marked Decision support Clinic
Time frame: change first 28 days in the study compared with the last 28 days
The Diabetes Treatment Satisfaction questionnaire
Includes eight items related to the diabetes treatment over the past weeks.
Time frame: change at week 16
WHO-5 Well-Being Index
Brief well-being questionnaire with five items in relation to previous 2 weeks
Time frame: change at week 16
The Patient Preferences for Patient Participation (4Ps)
The 4Ps is a questionnaire including 12 items comprising patient´s preferences as well as experiences.
Time frame: change at week 16